BACKGROUND: Glutathione S-transferases (GSTs) are important in intracellular binding and transport of numerous compounds, and play a central role in human detoxification processes. Human GSTs mainly consist of class Pi (GSTP), Mu (GSTM), Alpha (GSTA) and Theta (GSTT) enzymes, each subdivided into one or more isoenzymes. They catalyse the conjugation of glutathione (GSH) to toxic compounds, resulting in more water-soluble and less biologically active products that may be easily excreted. The reactive -SH group in GSH is provided by cysteine, an important amino acid in GSH synthesis. METHODS: GST expression, enzyme activity and concentrations of cysteine and GSH in cytosolic fractions of organs from an embryo and a fetus at 8 and 13 weeks gestational age respectively were investigated. RESULTS: GSTP 1 was predominantly present in all tissues of both the embryo and fetus. GSTA (GSTA 1 ⍣ GSTA 2 ) concentrations were moderate as compared with GSTP 1 , whereas GSTM 1 was present in only low amounts. GSTT 1 was not detected in any tissue. GST activity was highest in organs exposed directly to amniotic fluid. In all embryonic and fetal organs, considerable amounts of GSH and cysteine were detected, with higher GSH concentrations in organs where lower cysteine concentrations were demonstrated. CONCLUSIONS: These results suggest that in embryonic and early fetal development cysteine, GSH and GSTs are present in high amounts, and that GSTP 1 is the most important GST isoform at these developmental stages.
Introduction
The family of glutathione S-transferases (GSTs) consists of homo-or heterodimeric cystolic proteins composed of subunits with an estimated molecular mass of~25 kDa (range 23-28). Currently, four main subclasses of GST isoforms have been recognized in humans: Alpha, Mu, Pi and Theta (GSTA, GSTM, GSTP and GSTT respectively), each of which subdivide into one or more distinct isoforms with different reactivity towards specific substrates. Thus, a diverse expression pattern of GSTs isoforms is seen in the various adult tissues. GSTA is mainly expressed in liver, but it is also present in kidney, testis, adrenal gland and small intestine (Beckett and Hayes, 1993) , whereas GSTP 1 is mainly expressed in lung, placenta, breast and urinary bladder. GSTM 1 and GSTT 1 are found in relatively low concentrations in many organs. GSTs catalyse the conjugation of glutathione (GSH) with a wide variety of xenobiotics such as carcinogens and pharmacologically active agents, as well as reactive oxygen species. This conjugation may result in the formation of compounds with greater water-solubility but less biological activity, and these can easily be excreted in urine (Mukhtar et al., 1981; Beckett and Hayes, 1993; Hayes and Pulford, 1995; Stamler and Slivka, 1996; Knapen et al., 1999a) .
The characteristic feature of the tripeptide GSH (γ-glutamylcysteinylglycine) is the presence of the reactive sulphydryl (-SH) group donated by cysteine, and this dictates the chemistry of GSH. In addition to its role in detoxification, GSH is important in the storage and transport of amino acids (Stamler and Slivka, 1996) .
Embryonic and fetal growth and development depend on a constant flow of nutrients from the mother (Ronzoni et al., 1999) . During the first weeks of development, the embryo exchanges nutrients and waste products by diffusion, followed by exchange via the placental intravillous space. Despite the large detoxification capacity of the placenta (Knapen et al., 1999b; Zusterzeel et al., 1999) , almost every drug present in the maternal circulation is able to pass the placental barrier and may reach the fetal organs (Krauer and Dayer, 1991) . Therefore, cysteine and GSH may have a function in fetal detoxification in combination with GSTs, and this may be vital in the scavenging of toxic compounds that pass the placental barrier. Although concentrations of cysteine and GSH, together with the distribution of GST isoforms in combination with GST enzyme activity have been extensively studied in adult tissues, little is known at present about these compounds in both embryonic or fetal tissues; hence, the present study was initiated.
Materials and methods

Tissue samples
The study protocol was approved by the Institutional Review Board. After informed consent had been obtained from the patient, the stomach, small intestine, liver, kidney, adrenal gland, lung, heart and testes from a male extrauterine-located embryo of 8 weeks gestational age and a crown-rump length of 31 mm were excised on ice . Another male fetus of 13 weeks gestational age, with a crown-rump length of 85 mm, was removed from the uterus of a patient undergoing hysterectomy for cervical cancer and placed on ice, together with samples of decidual and placental tissues. The oesophagus, stomach, small intestine, liver, spleen, kidney, adrenal gland, lung, heart, bladder, testis, brain and brainstem of this fetus were excised on ice. The gestational ages of both the embryo and fetus had been confirmed by ultrasound examination. All tissue samples were frozen in liquid nitrogen and stored at -80°C until analysed.
Tissue homogenates were prepared on ice by adding 4 volumes of ice-cold homogenization buffer (0.25 mol/l saccharose, 20 mmol/l Tris/HCl buffer pH 7.4 and 1 mmol/l dithiothreitol). After five strokes using a glass-glass Potter tube, homogenates were centrifuged for 1 h at 100 000 g at 4°C. Immediately after centrifugation, the supernatant (cytosolic fraction) was removed and stored in aliquots at -80°C until analysed. Protein was determined using a published method (Lowry et al., 1951) using bovine serum albumin as a standard.
Quantification of GST isoforms
Concentrations of the GST isoforms were determined as described previously (Van Lieshout and Peters, 1998) . Samples of the embryo and fetus were run in parallel on different blots. In brief, cytosolic samples were subjected to sodium dodecylsulphate-polyacrylamide gel electrophoresis (12% acrylamide/bisacrylamide w/v, 37.5:1; BioRad Laboratories, Veenendaal, The Netherlands) and separated under standardized conditions. Subsequently, proteins were transferred to nitrocellulose membranes (Protran ® ; Schleicher and Schuell, s'Hertogenbosch, The Netherlands) using a semidry blotting system (Novablot II; Pharmacia, Uppsala, Sweden). After blocking with 1% gelatine (w/v) in phosphate-buffered saline-Tris (PBS-T) buffer, Western blots were incubated with monoclonal antibodies (ascites diluted 1:5000) against human GSTA (both A 1 and A 2 ) (Peters et al., 1992) , GSTM 1 (Peters et al., 1990) , GSTP 1 (Peters et al., 1989) and GSTT 1 (Juronen et al., 1996) as described previously in detail. After three wash cycles with PBS-T, specific binding of monoclonal antibodies to the isoforms was detected by incubation with peroxidaseconjugated rabbit anti-mouse immunoglobulin (Dakopatts, Glostrup, Denmark) followed by subsequent development of the peroxidase label with 0.1% 3,3Ј-diaminobenzidine in PBS (Sigma Chemical Co., Zwijndrecht, The Netherlands) containing 0.01% hydrogen peroxide (Merck, Darmstadt, Germany), 0.34 g/l imidazole (Merck) and 0.26 g/l cobalt chloride√6H 2 O (ICN Biomedicals B.V., Zoetermeer, The Netherlands). Staining intensity on the immunoblots was quantified using a laser densitometer (Ultroscan XL; LKB, Bromma, Sweden). Quantification of GST isoforms in the cytosolic fractions was performed with known amounts of purified GSTs, which were run in parallel with the samples. The detection limit of each GST isoform was~50 nmol/mg protein (Van Lieshout and Peters, 1998) ; the within-assay and day-to-day variations were 10 and 15% respectively.
Determination of GST enzyme activity
GST enzyme activity was determined in duplicate according to a published method (Habig et al., 1974) . In brief, 10 µl of each cytosolic fraction was added to 2.0 ml potassium phosphate buffer, 2446 pH 6.5, containing 1.0 mmol/l 1-chloro-2,4-dinitrobenzene (CDNB; Sigma Chemical Co.) and 5.0 mmol/l GSH (Sigma Chemical Co.) at 25°C in a disposable cuvette. The change in absorbance at 340 nm was followed for 3 min using a Lambda 12 spectrophotometer (Perkin Elmer, Nieuwerkerk a/d IJssel, The Netherlands).
Analysis of thiols
For the analysis of cysteine, homocysteine, cysteinylglycine and GSH, cytosols were diluted six times with 12% (v/v) perchloric acid, centrifuged for 5 min at 10 000 g, and subsequently 10 µl 10% (w/v) Tris (2-carboxyethyl) phosphine (Fluka Chemie AG, Bornem, The Netherlands) was added to 100 µl of each sample. After reduction for 30 min at room temperature, samples were neutralized by adding 75 µl 2 mol/l NaOH. Subsequently, 100 µl of the neutralized sample was derivatized with 7-fluorobenzofurazane-4-sulphonic acid (SBDF; Fluka Chemie AG) for 1 h at 60°C by adding 60 µl of derivatization buffer containing 50 µl borate buffer (125 mmol/l K 2 B 4 O 7 √4H 2 O and 4 mmol/l EDTA, pH 9.5), 5 µl SBDF (4 mg/ml borate buffer) and 5 µl NaOH (1.55 mol/l). Thiols were separated using highperformance liquid chromatography as described previously (Raijmakers et al., 2000) . Thiol concentrations were determined using a calibration curve for all thiols which was run in parallel with the samples.
Statistical analysis
In order to determine any associations between GSH concentrations, cysteine concentrations, GST isoforms and GST enzyme activity, the Spearman Rank coefficient of correlation was calculated using Astute for Microsoft Excel 5.0. A P-value of ഛ 0.05 indicated an association to be statistically significant.
Results
Concentrations of GST Alpha (A 1 ϩ A 2 : GSTA), Pi (GSTP 1 ), Mu (GSTM 1 ) and Theta (GSTT 1 ) in embryonic and fetal tissues are shown in Table I , together with details of GST enzyme activity with CDNB. A full analysis of all parameters was not possible due to insufficient amounts of material from some organs.
In the embryo of 8 weeks gestation, GSTP 1 was the predominantly expressed GST isoform in all tissue samples but one; only kidney mainly expressed GSTA instead of GSTP 1 . Overall, GST was composed of 23% GSTA, 73% GSTP 1 and 4% GSTM 1 . The highest GSTP 1 concentrations were seen in lung and stomach, but only in kidney was GSTP 1 expression much lower compared with other organs. The highest expression of GSTA was found in liver, whilst intermediate expression was detected in testis, kidney, small intestine and stomach, and low expression in the lung and adrenal gland. The presence of GSTA could not be demonstrated in the heart. The concentration of GSTM 1 expression was comparable in all tissues studied. GSTT 1 was not detected in any of the organs, which was consistent with a GSTT 1 null genotype found by polymerase chain reaction (PCR) analysis (Pemble et al., 1994) . All organs showed considerable GST activities towards CDNB, with the greatest enzyme activity being found in the stomach and small intestine.
In the fetus of 13 weeks gestation, GSTP 1 was also predominantly expressed in all organs, with highest concentrations in the small intestine, kidney and lung. Most other tissues had high GSTP 1 expression, except for spleen which showed relatively low concentrations. Overall, GST was composed of 26% GSTA, 69% GSTP 1 and 5% GSTM 1 . The highest expression of GSTA was seen in the liver, small intestine and adrenal gland, whilst moderate expression was seen in the oesophagus and low expression was seen in the spleen and lung. No GSTA was detected in the brain. GSTM 1 was mainly present in kidney and in tissues exposed to the amniotic fluid, these being the oesophagus, small intestine and lung. In all other tissues only moderate expression was found, except for the heart where only faint expression of GSTM 1 was seen. GSTT 1 was not detected in any of the fetal organs examined, but was found in considerable amounts in the decidua. PCR analysis revealed that this fetus also bore the GSTT 1 null genotype. GST enzyme activity was highest in the small intestine, with lower concentrations in the liver, adrenal gland, kidney and lung. In the other tissues only moderate enzyme activities were found, except for spleen where it was just measurable. Both the embryo and fetus showed considerable and similar amounts of acid-soluble GSH and cysteine in all organs examined, whereas concentrations of cysteinylglycine and homocysteine were much lower (Table II) . Overall, thiols were composed of 14% cysteine, 85% GSH, Ͻ1% cysteinylglycine and Ͻ1% homocysteine. Surprisingly, GSH concentrations in liver tissues were very low, whereas the cysteine concentration was high compared with other organs. In the embryo, the highest cysteine concentrations were found in the liver and testis, while low amounts were found in kidney and lung compared with other organs. GSH concentrations were highest in the stomach, lung, heart and kidney, but almost undetectable in the liver. In the fetus, the liver and small intestine showed the highest amounts of cysteine compared with other tissues, but almost none was detected in the oesophagus and spleen. High GSH concentrations were found in the adrenal gland, heart, brain and brainstem, whilst the lowest concentrations were in the liver, testis and spleen. Expression of GST isoforms in placental and decidual tissues, which were obtained in parallel with the fetus, was comparable with that in the fetal organs. Both placenta and decidua mainly expressed GSTP 1 . A relatively high concentration of GSTT 1 was found in decidua, whereas GSTA in decidua and GSTM 1 in placenta and in decidua were only expressed at relatively low concentrations. GST enzyme activity was comparable in placenta and decidua, though activities were lower in comparison with that of most fetal organs. In both placenta and decidua thiol concentrations were comparable with those in most fetal tissues, except for cysteine in decidua where a high concentration was found.
Significant correlations between GST enzyme activity and expression of GSTA (r s ϭ 0.61, P Ͻ 0.05), GSTP 1 (r s ϭ 0.48, P ϭ 0.03) and the sum of all GST isoforms (r s ϭ 0.59, P ϭ 0.005) were found in the fetus, whereas in the embryo no such correlations could be found. A significant inverse correlation between cysteine and GSH was found in the embryo (r s ϭ -0.74, P ϭ 0.04). 
Discussion
To date, several studies have described thiol concentrations and the expression and enzyme activity of GSTs in fetuses of comparable gestational age (Table III) . Although data from only one embryo and one early fetus are presented in the current study (in contrast to earlier studies on the development of GSTs), quantitative data are presented for a wide range of tissues, thereby allowing a direct comparison to be made between organs. All tissues examined expressed considerable amounts of cysteine, GSH and GSTs P 1 , A 1 ϩ A 2 and M 1 , and showed a substantial GST enzyme activity, though in variable amounts. It was striking, therefore, that GSTT 1 was not detected in all the embryonic and fetal tissues examined, but was found only in maternal decidual tissue of the fetus. A null genotype of the GSTT 1 locus exists which has a frequency of 10-30% in a normal Western European population (Kempkes et al., 1996) . Both the embryo and fetus were of the GSTT 1 null genotype, and consequently were unable to express GSTT 1 . In general, GSTP 1 is the predominantly expressed GST isoenzyme in embryonic and early fetal organs, whereas expression of GSTA and GSTM 1 is moderate and low respectively. These results are in line with those previously reported (Beckett et al., 1990) , also indicating that GSTP 1 is the most important GST during fetal development.
In liver, a relatively high expression of GSTM 1 was found, and this contrasted with data reported by others (Strange et al., 1984 (Strange et al., , 1985 , who found no or only faint GSTM 1 expression in fetuses of 10-20 weeks gestation using starch gel electrophoresis. In accordance with these studies, high concentrations of GSTA and GSTP 1 were also found in the current study. A higher GST enzyme activity was also found in both the embryo and fetus compared with other data (Strange et al., 1984) , and this might be explained by the high expression levels of GSTM 1 . In adult liver, GSTA is predominantly expressed whereas GSTP 1 is seen only in the bile duct epithelium and blood vessels (Mulder et al., 1994) . However, in embryonic liver GSTP 1 is the most expressed GST isoenzyme, indicating that the expression of GSTM 1 and GSTA increases during human development, whilst expression of GSTP 1 decreases, as reported elsewhere (Beckett et al., 1990) . These changes in the expression of GST isoforms might also explain the higher GST enzyme activity in adult liver reported earlier (Mulder et al., 1994) . The different GST isoenzymes expressed in the developing liver, and the lower GST enzyme activity as compared with adult liver, are in agreement with the different functions of embryonic, fetal and adult liver. In the developing liver, the synthesis of erythrocytes is the main function, whereas in adults the biotransformation of toxic compounds is one of the primary functions.
In lung, a similar expression of GST isoforms as found in the current study was described previously (Beckett et al., 1990) ; concentrations of GSTP 1 were high in early gestation, but decreased during gestation, whereas GSTM 1 and GSTA expression were moderate and weak respectively. During gestation, GST enzyme activity decreased in parallel with GSTP 1 expression (Fryer et al., 1986) , the GST enzyme activity remaining low in samples obtained more than a year after birth. In adult tissue, GSTP 1 still is by far the most predominant GST isoform (Antilla et al., 1993; Rowe et al., 1997) ; however, the concentrations were approximately twofold lower than in fetal tissue. GST enzyme activities were found to be much lower in adult than in fetal lung tissue (Mukhtar et al., 1981; Clapper et al., 1991) . When fully functional, the placenta, which has a large detoxification capacity (Knapen et al., 1999b; Zusterzeel et al., 1999) , removes toxic metabolites from the fetal circulation. Amniotic fluid may also contain toxic metabolites, and therefore tissues exposed to the amniotic fluid (e.g. lung and gastrointestinal tract) may need to adapt to such an environment. The high concentration of GSTP 1 and high enzyme activity of lung tissue in early gestation, when compared with other tissues as well as with adult concentrations, may represent such an adaptation.
With the exception of the low GSTP 1 expression in the embryo, the expression pattern of GST isoforms in kidney in the current study were in line with those reported previously (Beckett et al., 1990) , these being high, moderate and faint expression of GSTP 1 , GSTA and GSTM 1 respectively. In contrast to the results of others (Strange et al., 1985) who found GSTA to be absent from fetal kidney, a moderate expression of this GST subclass was measured. In fetal kidney, concentrations of GST isoforms and enzyme activity were similar to those found in adult tissues, where the predominantly expressed GST isoform was shown to be GSTA Eickelmann et al., 1994; Rowe et al., 1997; Rodilla et al., 1998) . This similarity might indicate that GST subclass development is an early event of pregnancy.
Very similar results were found in the literature for the expression and activity of GST isoforms in adult tissues, including brain (Rowe et al., 1997) , oesophagus and stomach (Peters et al., 1993) compared with embryonic and fetal tissues (Table IV) . In contrast, values in adult bladder differ considerably compared with corresponding fetal values (Berendsen et al., 1997) . These discrepancies and similarities between adult and fetal GST capacity may indicate the different development patterns for the various fetal organs.
In the current study, mean concentrations of cysteine and GSH were comparable in the embryo and fetus examined. The inverse association between GSH and cysteine concentrations in the embryo may point to the importance of availability of Table IV . Glutathione S-transferase (GST) isoforms and enzyme activity in adult tissue free cysteine in the synthesis of GSH or of its storage function (Stamler and Slivka, 1996) . Nutritionally obtained cysteine is the only -SH-containing amino acid available for GSH synthesis during development, due to the absence in early gestation of a cystathionine pathway that, in adults, trans-sulphurates methionine through homocysteine to cysteine (Viña et al., 1995) . Cysteine concentrations in embryonic and fetal liver were higher than those of GSH, which contrasts with the concentrations in most other organs and with the situation in adult liver, where GSH concentrations are much higher. This may be explained by functional differences: one of the main functions of adult liver is its role in detoxification, whereas in early gestation liver has mainly a haematopoetic function. It has been reported previously (Rollins et al., 1981) that only a small fraction of the detected -SH residues in fetal liver corresponded to GSH, and that most -SH residues originated from cysteine, which was present in greater amounts than was GSH. However, these authors suggested that artefactual events may have occurred during sample preparation and handling to explain these results, since GSH can easily be metabolized to cysteine after fetal death, due to the presence of high fetal γ-glutamyltranspeptidase enzyme activity. However, they do not rule out the possibility of high cysteine concentrations in fetal liver.
As compared with adults, the GSH concentrations in embryonic and fetal lung and bladder were approximately sixfold (Cook et al., 1991) and two-fold (Giralt et al., 1993; Singh et al., 1994; Pendyala et al., 1997) higher respectively. The results in lung might be explained by the finding that GSH concentrations are coupled to the expression of GST isoenzymes and enzyme activity, both of which are very high during early gestation but decrease two-fold in adults (Fryer et al., 1986; Rowe et al., 1997) . This change in GSH concentration, GST expression and GST enzyme activity during gestation might be explained by the development of the placenta. In early gestation, the placenta is not fully developed, and subsequent adaptations must be made to prevent damage by toxic products, which are by preference excreted into the 2449 amniotic fluid. Thus, tissues exposed to the amniotic fluid most likely have higher concentrations of GSH, GSTs and a higher enzyme activity. When placental detoxification begins to function and waste products are removed from the fetal circulation, this adaptation is no longer necessary and consequently both the concentration of GST and the enzyme activity may be reduced.
Although the placenta and decidua are partly and totally from maternal origin respectively, both tissues most likely play an important role in fetal detoxification and protection during growth and development. In the current study, GST enzyme activity in the placenta and decidua was comparable with that in previous studies in early pregnancy (Di Ilio et al., 1983) and in term placenta and decidua (Polidoro et al., 1980; MutluTurkoglu et al., 1998; Knapen et al., 1999b) . However, the expression of all GST isoforms found here was much higher compared with the concentrations reported in term placenta and decidua (Zusterzeel et al., 1999) , and this may point to another function of the placenta in early gestation as compared with third-trimester placenta. In placenta and decidua tissue, similar concentrations of GSH were found. Although placental GSH concentrations and GST enzyme activities were similar in the current study, the GSH concentration in term decidua appeared to be much higher than was reported earlier (Knapen et al., 1999b) . These authors found the GSH concentration in decidua to be about five-fold higher than in placenta, perhaps indicating that decidual GSTs found in early gestation have other functions or are less important than in third-trimester pregnancy.
In conclusion, it has been shown that during the early stages of embryonic and fetal development, cysteine, GSH, GST isoforms and GST enzyme activity were expressed in considerable amounts in most tissues examined. In contrast to adult tissue, GSTP 1 was the predominant GST isoform in embryonic and fetal organs. However, only moderate concentrations of GSTA and GSTM 1 were found compared with adults, and this might point to different functions of GSTs in the tissues of the embryo and/or fetus than in those of adults.
